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ABSTRACT
RNAs are post-transcriptionally modified by dedi-
cated writer or eraser enzymes that add or remove
specific modifications, respectively. Mass spectrom-
etry (MS) of RNA is a useful tool to study the mod-
ification state of an oligonucleotide (ON) in a sen-
sitive manner. Here, we developed an ion-pairing
reagent free chromatography for positive ion detec-
tion of ONs by low- and high-resolution MS, which
does not interfere with other types of small com-
pound analyses done on the same instrument. We
apply ON-MS to determine the ONs from an RNase
T1 digest of in vitro transcribed tRNA, which are
purified after ribozyme-fusion transcription by auto-
mated size exclusion chromatography. The thus pro-
duced tRNAValAAC is substrate of the human tRNA
ADAT2/3 enzyme and we confirm the deamination of
adenosine to inosine and the formation of tRNAValIAC
in vitro by ON-MS. Furthermore, low resolution ON-
MS is used to monitor the demethylation of ONs
containing 1-methyladenosine by bacterial AlkB in
vitro. The power of high-resolution ON-MS is demon-
strated by the detection and mapping of modified
ONs from native total tRNA digested with RNase T1.
Overall, we present an oligonucleotide MS method
which is broadly applicable to monitor in vitro RNA
(de-)modification processes and native RNA.
INTRODUCTION
Ribonucleic acids (RNA) contain a vast variety of chemi-
cal modifications, which derive from the four canonical nu-
cleosides adenosine, guanosine, uridine and cytidine. Mod-
ifications are introduced by dedicated enzymes, sometimes
referred to as RNA writers. In analogy, RNA erasers exist,
which demethylate adenosine in messenger RNA (mRNA)
(1,2) or transfer RNA (tRNA) (3,4).ManyRNAmodifying
enzymes add methyl groups to either the nucleobase or the
ribose. For example, tRNA methyltransferase 1 (TRMT1)
is responsible for the dimethylation of guanosine to 2,2-
dimethylguanosine in tRNA (m22G) (5) and methyltrans-
ferase like proteins 3/14 (METTL3/METTL14) methylate
position 6 of adenosine and the epitranscriptomic mark
m6A forms in mRNA. In addition to RNA modification
by methylation, the conversion of adenosine to inosine by
deaminases such as the adenosine deaminase tRNA spe-
cific enzyme 2/3 (ADAT2/3) has been reported (6). Inter-
estingly, many neurological diseases are connected withmu-
tations in RNA modifying enzymes such as TRMT1 (5)
and ADAT2/3 (7). In addition to the active decoration of
RNA with modifications, the removal by active demethy-
lation is also possible. Demethylation of m6A and its ri-
bose methylated variant m6Am has been reported in hu-
man mRNA (1,2). Bacterial RNAs, including tRNA and
rRNA, are also methylated, however there are no reports of
active demethylation of enzymatically methylated sites. In
many bacteria, the methylation of adenosine at position N1
(1-methyladenosine, m1A) is not found in DNA or tRNA.
However, alkylation stress can lead to direct m1A formation
inDNAandRNA.Due tomethylating agents, which chem-
ically methylate nucleic acids, bacteria have the ability for
active demethylation. This m1A is removed by the alpha-
ketoglutarate-dependent dioxygenase AlkB (8). In human
tRNAs, m1A is found in 42% of all tRNAs at position 58.
m1A58 has been reported to be substrate to the human ho-
mologues of AlkB, namely ALKBH1 (3) and ALKBH3 (9).
The detection of modified moieties in RNA is possible
by chemical means (10), by sequencing (11) and mass spec-
trometry (MS) (12). Even with the ever-rising number of
sequencing techniques, which detect modified nucleosides
in whole transcriptomes, MS remains the key technique for
characterization of modified nucleosides. RNAMS analyt-
ics can be subdivided into three major principles. The first
relies on complete enzymatic digestion of the RNA into
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the nucleoside building block and is highly sensitive with
lower limits of detection (LLOD) in the fmol and amol
range (nucleoside-MS). This technique is commonly used
for detection (12), quantification (13) or discovery (14,15)
of modified nucleosides. The second uses enzymes, which
only partially digest the RNA and smaller oligonucleotides
(ON) emerge (in this manuscript referred to as ON-MS).
In the case of ON-MS, some of the sequence context sur-
rounding a modified nucleoside is preserved and the tech-
nique is used to place modified nucleosides in known and
unknown RNA sequences. Here, the pioneering work of
the McCloskey (16,17), Limbach (18) and Suzuki (19) lab
have largely contributed to the establishment of ON-MS.
Disadvantages of this bottom-up approach are the loss of
(most) sequence information, congestion of peaks in a small
mass range, which mess up spectra, as well as the detec-
tion loss of low-abundant-modified RNAs by domination
of their unmodified counterparts (20–22). The third princi-
ple ofMS-basedRNAanalytics is the analysis of full-length
RNAs (top-down-MS) at sophisticated mass spectrometers
which has been pioneered by the Breuker lab (23–26). Top-
down-MS of RNA is suited for many types of modifica-
tion and it reveals the sample heterogeneity. It provides a
high sequence coverage and information without a time-
consuming digestion step. The disadvantage of top-down
approaches is the need for RNA shorter ∼60 nts and the
available dissociation steps in theMS field are low-efficiency
processes. Another challenge is the underdevelopment of
back-end bioinformatic tools. Nevertheless, quantitation of
modified nucleobases has been also shown by top-down-
MS (27). Both bottom-up- and top-down-MS approaches
utilize MS/MS analysis and the underlying RNA dissocia-
tion reactions have been reviewed (28). From the perspective
of instrumentation, high-resolution mass spectrometers are
ideally suited for theMS andMS/MS analysis of RNA and
its fragments. Instruments, such as time-of-flight, iontrap
or orbitrap MS, deliver the necessary resolution to deter-
mine the charge state of the ONs and they allow sequence
prediction based on their accuracy. Low resolution instru-
ments, such as triple quadrupoleMS, are not commonly ap-
plied for oligonucleotide MS analysis as they lack the reso-
lution to distinguish similar ONs and to clearly determine
the charge state of an ionized ON.
In contrast to top-down-MS, bottom-up-MS relies on
the chromatographic separation of the ONs to solve the
problem of congested MS spectra. The liquid chromatog-
raphy is achieved by using an RP-18-based column and
an ion-pairing reagent such as triethyl-ammonium-acetate
(TEAA), which separates the oligonucleotides by their
length. The eluting oligonucleotides are then analyzed in
negative ionization mode by a high-resolution mass spec-
trometer and sequenced according to their fragmentation
pattern (29,30) or modification footprints (31).With TEAA
dependent flow chromatography (32), it is now possible to
analyze 2–5 ng of purified tRNA isoacceptors (∼80–200
fmol pure tRNA) and determine the sequence and modifi-
cation status of these tRNAs (33). Due to the common use
of organic bases as ion-pairing reagents for ON separation
and thus negative ionization, oligonucleotide MS is mostly
used in labs with liquid chromatography coupledmass spec-
trometry (LC-MS) instruments dedicated for ON analysis.
For other labs, the limitation of using ion-pairing reagents
is the difficulty of their removal from the instrument. Resid-
ual ion-pairing reagents stay on the LC system and interfere
with other types of chromatography and in addition they
reduce the sensitivity of the mass spectrometer. To over-
come this problem ion-pairing reagent free chromatography
can be used on a reverse phase (RP) column (34). Here, the
retention behavior of oligonucleotides is unexplored. An-
other alternative is chromatography on a hydrophilic inter-
action liquid chromatography (HILIC) column which will
allow separation in a similar fashion to ion-pairing chro-
matography (35). Both methods are reported in combina-
tion with negative ionization mode MS detection and are
thus not applicable for labs with mass spectrometers that
preferably operate in positive ionization mode. Recently, a
method was presented which used positive ionization detec-
tion of oligonucleotides after ion-pairing chromatography
(36). Thus, laboratories have currently the option of doing
classical ON-MS (ion-pairing reagent chromatography in
negative ionization mode), ion-pairing reagent free ON-MS
in negative mode or ion-pairing chromatography in positive
mode. Thus, there is currently no method available which
overcomes both limitations for a broad application of ON-
MS.
A general challenge for MS-based modification analysis
is its non-quantitative nature. For quantification, the signal
intensity of an analyte must correlate with its concentration
or amount. In MS, the signal intensity depends of course
on the amount of analyte, but in addition on a multitude
of other parameters such as salt load, ionization properties
of the analyte, instrument parameters and so on. These de-
tection fluctuations make quantification by MS a challeng-
ing task, which can only be done by using stable isotope
labeled internal standards (SILIS) of the analyte of inter-
est. For nucleoside-MS, this problem has been overcome by
synthetic (37) or biosynthetic (13,38) preparation of stable
isotope labeled nucleosides. For ON-MS, biosynthetic ap-
proaches have been reported (39,40). Another elegant way
to solve the problem was presented by the Limbach lab
(41). They performed the enzymatic digest of the unknown
RNA in the presence of H218O, which results in oxygen-18
incorporation into the oligonucleotide 3′-phosphate. As a
third option, in vitro transcribed RNA is prepared in the
presence of stable isotope-labeled nucleoside triphosphates
(NTP) that is then used as an internal standard (42,43).
Although ON-MS has become a powerful tool for anal-
ysis of RNA modifications within their sequence context,
it is not commonly applied. Due to the benefits of ON-
MS, we developed a TEAA free chromatography, which
separates the ONs not by length, but by chemical compo-
sition of the sequence. In this manuscript, we describe the
development and separation principle of the method us-
ing synthetic ONs. Detection is achieved by low-resolution
and high-resolution MS in positive ionization mode. We
present MS/MS data for the analyzed ONs and determine
the LLOD in various detection modes. We describe the au-
tomated purification of unlabeled and stable isotope labeled
in vitro transcripts of tRNAValAAC and tRNASerUGA by ri-
bozyme fusion transcription. These in vitro transcripts and
native tRNA from HEK cells are analyzed by our ON-
MS method. To verify correct folding of the produced tR-
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NAs, we use the adenosine-to-inosine deaminating enzyme
ADAT2/3 on tRNAValAAC. Inosine formation is observed
by both nucleoside-MS and ON-MS. Importantly, these ex-
periments are done on the same day using the same in-
strument which highlights the compatibility of our ON-MS
method with sensitive small compound analysis. Further-
more, we use the developed ON-MS method to monitor
the demethylation of short oligonucleotides containing 1-
methyladenosine by bacterial AlkB in vitro.
Overall, we provide a method for automated purifica-
tion of RNA transcripts and a broadly applicable ON-MS
method for instruments commonly used for other types of
small compound analysis, especially nucleoside analysis.
MATERIALS AND METHODS
Salts, reagents and nucleosides
All salts, solvents and reagents were obtained from Sigma
Aldrich (Munich,Germany) atmolecular biology grade un-
less stated otherwise. All solutions and buffers were made
with water from aMillipore device (Milli-Q, Merck, Darm-
stadt, Germany). Nucleosides: adenosine (A), cytidine (C),
guanosine (G) and uridine (U) were purchased from Sigma
Aldrich. 1-methyladenosine (m1A) and inosine (I) were pur-
chased from Carbosynth (Newbury, UK).
Oligonucleotides
All oligonucleotides were delivered in a stock concentration
of 100 M in water and are listed in Supplementary Table
S1.
AlkB in vitro assay
An aliquot of bacterial AlkB protein (Peak Proteins,
Cheshire, UK) was thawed on ice. Every assay was per-
formed in a volume of 50 l with a final concentration of
50 mM TRIS HCl pH 7.5, 15 mMKCl, 2 mM L-ascorbate,
300 M -ketoglutarate, 300 M Fe(II) (NH4)2(SO4)2
× 6H2O. L-ascorbate, -ketoglutarate and diammonium
iron (II) sulfate hexahydrate stock solutions were made
afresh. A total of 10 M of the synthetic RNA oligonu-
cleotide was incubated with 1 MAlkB enzyme. All assays
were incubated at 37◦C for 1 h and immediately stopped af-
terward by filtering through a molecular weight cut-off fil-
ter (VWR, Partnumber: 516-0229) for oligonucleotides or
RNA precipitation for tRNA in vitro transcripts, respec-
tively.
tRNA digestion for nucleoside mass spectrometry
Up to 1 g RNA in 30 l aqueous digestion mix were di-
gested to single nucleosides by using 0.2 u Alkaline Phos-
phatase, 0.02 u Phosphodiesterase I (VWR, Radnor, PA,
USA) and 0.2 u Benzonase in 5 mM TRIS (pH 8.0)
and 1 mM MgCl2. Furthermore, 0.5 g tetrahydrouridine
(Merck, Darmstadt, Germany), 1 M butylated hydroxy-
toluene and 0.1 g pentostatine were added. The mixture
was incubated with the RNA for 2 h at 37◦C and filtered
through 96-well filterplates (AcroPrep™ Advance 350 10 K
Omega™, PALL Corporation, New York, USA) at 4◦C for
30 min at 3000 × g, or through single tubes (VWR, Part-
number: 516-0229) at room temperature for 7min at 5000×
g. The filtrate was mixed with 1/10 Vol. of 10× yeast SILIS
(stable isotope labeled internal standard) (38) for absolute
quantification.
Nucleoside mass spectrometry
For nucleoside-MS measurements, a liquid chromatogra-
phy unit (1290 Infinity II, Agilent Technologies, Wald-
bronn, Germany) equipped with a diode-array detector
(DAD, Agilent Technologies) was used that was interfaced
with a triple quadrupole mass spectrometer (G6470A, Ag-
ilent Technologies) via an electrospray ionization (ESI)
source (Jet Stream,Agilent Technologies). For separation of
nucleosides, a Synergi Fusion-RP column (Phenomenex®,
Torrance, California, USA; Synergi® 2.5 m Fusion-RP
100 A˚, 150× 2.0mm) at 35◦Cand a flow rate of 0.35ml/min
were used. The eluents were 5 mM NH4OAc, brought to
pH 5.3 with glacial acetic acid (buffer A), and pure acetoni-
trile (buffer B). The gradient started at 100% A for 1 min,
followed by an increase of solvent B to 10% over 5 min.
From 5 to 7 min, solvent B was increased to 40% and was
maintained for 1 min before returning to 100% solvent A
in 0.5 min and a 2.5 min re-equilibration period. The QQQ
mass spectrometer was operated in dynamic multiple reac-
tion monitoring (dMRM)mode between 1.1 min and 9 min
with a cell accelerator voltage of 5 eV. Operating parame-
ters: positive-ion mode, skimmer voltage of 15 V, cell accel-
erator voltage of 5 V, N2 gas temperature of 230◦C and N2
gas flow of 6 l/min, sheath gas (N2) temperature of 400◦C
with a flow of 12 l/min, capillary voltage of 2500 V, nozzle
voltage of 0 V and nebulizer at 40 psi. The detailed mass
spectrometric parameters for each nucleoside are given in
Supplementary Table S2.
Calibration for nucleoside mass spctrometry
For calibration, synthetic nucleosides Cytidine, Uridine,
Guanosine, Adenosine, 1-methyladenosine (m1A) and In-
osine (I) were weighed and dissolved in water to a stock
concentration of 1–10 mM. Calibration solutions ranging
from 0.15 to 500 pmol for each canonical nucleoside and
from 0.15 to 500 fmol for each modified nucleoside were
prepared by serial dilution (1:10). The calibration solutions
were mixed with 1/10 Vol. of 10× yeast SILIS and ana-
lyzed by nucleoside-MS.Data were analyzed usingAgilent’s
Quantitative or Qualitative Software. The absolute amount
determined for m1A and I was normalized to the amount
of injected RNA as determined by the absolute abundance
of all four canonical nucleosides (38).
Mammalian cells
HEK293T andHeLaACC 57 cells (DSMZ, Braunschweig,
Germany) were cultured in Dulbecco’s Modified Eagle
Medium (DMEM). DMEM medium was prepared by dis-
solving 8.4 g DMEM powder D5030 in 1 l pure water. Be-
fore sterile filtration, carbonate and phenol red were added
to a final concentration of 3.7 g/l NaHCO3 and 0.0159 g/l
phenol red. Stocks of glucose (225 g/l) and L-glutamine
e41 Nucleic Acids Research, 2020, Vol. 48, No. 7 PAGE 4 OF 16
(15 g/l) were prepared and sterile filtered. These solutions
were added to the DMEM medium before usage to a final
concentration of 4.5 g/l glucose, 0.584 g/l L-glutamine and
10% fetal calf serum (FCS). The methionine concentration
was 0.15 g/l in the final media. For splitting, the cells were
treated with TrypLE Express (Gibco, Carlsbad, CA, USA).
The cells were incubated and cultivated at 10% CO2 atmo-
sphere.
RNA isolation
HEK and HeLa cells were harvested directly in cell culture
flasks using 1 ml TRI-Reagent® per 25 cm2. Isolation was
performed according to the manufacturer’s protocol with
chloroform (Roth, Karlsruhe, Germany). The RNA was fi-
nally dissolved in 30 l water.
PCR
All polymerase chain reactions (PCR) were performed in
a total volume of 50 l with a final concentration of 1-
fold Phusion Buffer HF (New England Biolabs, Ipswich,
MA, USA) and 0.8 M forward and reverse primer. The
sequence of templates and primers are given in Supplemen-
tary Table S1. Additionally, 1 l dNTPs, 0.5 l Phusion
polymerase and 100 ng of the desired DNA template were
added. All samples were amplified with the same PCR pro-
gram: 95◦C for 2 min, 95◦C for 30 s for 20 amplification
cycles, 57◦C for 30 s for 20 times and 68◦C for 1 min for
20 times. At the end of the program, the PCR reaction was
incubated at 68◦C for 1 min and was cooled down to 4◦C.
Every PCR reaction was performed twice and pooled after-
ward for the T7 in vitro transcription.
T7 in vitro transcription
The total volume of the T7 in vitro transcription was 200l.
A total of 100 l PCR product were added to T7 buffer mix
andT7 enzyme (TranscriptAid T7HighYield Transcription
Kit, Thermo Fisher Scientific, Waltham, MA, USA) and
1.6 l of each rNTP (14N-rNTPs were provided by the kit,
15N-rNTPs were purchased by Silantes, Munich, Germany,
Partnumber.: 121306100). The mixture was incubated for
2 h at 37◦C and 600 rpm. After 2 h incubation, the sample
was treatedwith 2l T7 enzymemix and 5l 50mMMgCl2
and incubated for additional 2 h. After another 2 h incuba-
tion, the sample was treated again with 2 l T7 enzyme mix
and 5 l 50 mM MgCl2 and incubated for additional 2 h
to improve the yield of the transcription. In total, the tran-
scriptionwas finished after 6 h.DNA template was removed
by addition of 4 l DNase 1, which is provided in the kit,
1 h at 37◦C. In the next step, MgCl2 was added with a fi-
nal concentration of 5 mM and the sample was incubated
at 60◦C for 1 h to auto-catalytically cleave the precursor in
vitro transcript into its target tRNA. Prior to RNA precip-
itation, the sample was centrifuged at 5000 × g for 5 min at
room temperature to remove the insoluble pyrophosphate
of the transcription reaction. The supernatant was precipi-
tated by addition of 0.1 Vol. of 5 M ammonium acetate and
2.5 Vol. of ice-cold ethanol (100%) followed by overnight
incubation at −20◦C. The RNA was pelleted by centrifuga-
tion (12 000 × g, 40 min, 4◦C), washed with 70% ethanol
and resuspended in 30 l water.
Size exclusion chromatography (SEC)
For purification of tRNA from total RNAor purification of
tRNA in vitro transcripts from precursor products, size ex-
clusion chromatography (SEC)was used on anAgilent 1100
HPLC system (Degasser, G1279A; Quad Pump, G1311A;
ALS, G1313A; COLCOM, G1316A; VWD, G1314A; An-
alyt FC,G1364C). Formethod development, three columns
with 7.8 × 300 mm, 2.7 m particle size from Agilent
(Waldbronn, Germany) were tested. The SEC-3 (Partnum-
ber: 5190-2511 reported by Dedon lab (44)), the Advance-
Bio 300 A˚ (Partnumber: 1180-5301) and the AdvanceBio
130 A˚ (Partnumber: 1180-5350).
The column temperature was set to 40◦C for native tRNA
purification using the Advance Bio 300 A˚ and 60◦C for in
vitro transcript purification using the AdvanceBio 130 A˚.
For elution, a 1 ml/min isocratic flow of 0.1 M ammonium
acetate was used. Eluting RNAwas detected at 254 nmwith
a diode array detector. The eluted RNA was collected by a
fraction collector and the eluent was evaporated (GeneVac,
EZ-2 PLUS, Ipswich, UK) to a volume of ∼50 l before
ethanol precipitation. The purified RNA was dissolved in
30 l water for further enzymatic assays or MS analysis.
Handling guide for SEC columns
For prolongation of the column lifetime, it is essential to
avoid sudden pressure changes. Thus we recommend to run
a conditioning method, which slowly increases the flow rate
from 0 ml/min to 1 ml/min within 20 min. For tRNA pu-
rification from total RNA, a column temperature of 40◦C
is sufficient. For purification of in vitro transcripts, 60◦C
yielded better separation results. Note: Column lifetime is
shortened at 60◦C and thus long exposures to high temper-
atures should be avoided. After use, the column was stored
in 0.05% NaN3.
RNA concentration and quality measurements
The RNA concentration was determined with an Implen
Nanophotometer NP 80 (Munich, Germany). For quality
control of SEC purified in vitro transcripts, the Agilent 2100
Bioanalyzer (Small RNA analysis chip, Partnumber: 5067-
1548, Agilent, Waldbronn, Germany) was used.
Isoacceptor purification
The procedure was adapted from Hauenschild et al.
(45). For tRNA isoacceptor purification, pre-purified to-
tal tRNA was used. The sequence of the biotinylated 2′-
deoxyoligonucleotide probes is listed in Supplementary Ta-
ble S1.
Purification of ADAT2/3
Open Reading Frame sequences encoding for human
ADAT2 and ADAT3 were cloned into the petDuet plas-
mid. ADAT2 was cloned intoMultiple Cloning Site (MCS)
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1 which allows fusion with a HIS tag. ADAT3 was cloned
intoMCS2. BL21DE3 RIPL Escherichia coli cells (Agilent)
were transformed with the above plasmid. Starter culture
was grown to an O.D of 0.1–0.5, and inoculated into a
larger culture to an O.D of 0.05 and cells were induced with
Isopropyl--D-thiogalactoside (IPTG) at an O.D. of 0.6–
0.8. After induction, E. coli were grown at 20◦C for 15 h.
Cells were harvested and lysed by sonication in a buffer con-
taining 20 mM TrisHCl pH 7.6, 5% glycerol, 0.1% Triton,
1 mM Dithiothreitol (DTT), 0.1 mM (Phenylmethylsul-
fonylfluorid) PMSF, 500 mMNaCl, 25 mM imidazole. Cell
lysates were oscillated with HisPur Colbalt Resin (Thermo
Scientific # 89964) at 4◦C for 2 h. Beads were washed 3×
with buffer containing 20 mM TrisHCl pH 7.6, 5% Glyc-
erol, 0.1% Triton, 1 mM DTT, 0.1 mM PMSF, 300 mM
NaCl and 25 mM imidazole. Elution of protein was car-
ried out with above buffer containing 300 mM imidazole.
Elution buffer was exchanged to buffer containing 20 mM
TRIS, 5% Glycerol, 0.1% Triton, 150 mMNaCl and 1 mM
DTT. Expression and purification was verified by sodium
dodecyl sulphate-PAGE (polyacrylamide gel electrophore-
sis) followed by western blotting. Quantification of purified
protein was carried out by Coomassie with BSA size stan-
dards. Final concentration of ADAT2/3 was ∼8 ng/l.
ADAT2/3 assay
An aliquot of ADAT2/3 protein was thawed on ice. A to-
tal of 6 l tRNA substrate (115 ng/l) were incubated in
6l water and 6l melting mix. Themelting mix buffer was
prepared with 30 mM TRIS pH 7.5 and 1 mM ethylenedi-
aminetetraacetic acid. To denature the tRNA, the mix was
heated to 95◦C for 2 min and immediately placed on ice for
3 min for tRNA folding. In the next step, 3 l folding mix
was added and incubated for 20 min at 37◦C. The folding
mix buffer was prepared with final concentrations of 333
mM HEPES pH 7.5, 20 mMMgCl2 and 333 mM NaCl. A
total of 9 l of ADAT2/3 was added to obtain a total re-
action volume of 30 l and incubated for 1 h at 37◦C and
immediately stopped afterward by RNA precipitation with
300 l LiClO4 in acetone (2%). After incubation at room
temperature for 5 min, the sample was centrifuged at 5000
× g for 5min. The supernatant was discarded and the tRNA
pellet was solved in 20 l milliQ water for further analysis.
tRNA digestion for oligonucleotide mass spectrometry
RNase T1 was diluted to a 10 U/l solution by mixing 2 l
of the RNase T1 stock (186 U/l, Sigma-Aldrich, Munich,
Germany) with 35.2 l TRIS pH 7.5 (25 mM). The diluted
RNase T1 should be stored at 4◦C. Up to 1 g RNA was
digested with RNase T1 at 37◦C for 1 h in a total volume
of 50 l with final concentrations of 25 mM TRIS pH 7.5,
100 mMNaCl and 1 U/l RNase T1 and 0.2 u/l Alkaline
Phosphatase. The digested samples were filtered through
a molecular weight 10 kDa cut-off filter (VWR, Dreieich,
Germany, Partnumber: 516-0229) and analyzed by MS.
Oligonucleotide mass spectrometry
For oligonucleotide MS measurements, the instrument de-
scribed in the nucleoside-MS section was used. For sep-
aration of oligonucleotides, a Synergi Fusion-RP column
(Phenomenex®, Torrance, CA, USA; Synergi® 2.5 m
Fusion-RP 100 A˚, 150× 2.0 mm) at 35◦C and a flow rate of
0.35 ml/min were used. The eluents were 10 mM NH4OAc
(pH 7.0) (buffer A) and pure acetonitrile (buffer B) (Carl-
Roth, Karlsruhe, Germany; LC-MS grade, purity ≥95.95).
The gradient started at 100% buffer A, followed by an in-
crease of B to 5% over 10 min. From 10 to 12 min, buffer
B was increased to 50% and was maintained for 1 min be-
fore returning to 100% buffer A and a 4min re-equilibration
period. For source optimization experiments a shorter gra-
dient was used starting at 100% buffer A, increased to 2%
buffer A over 1 min, increased to 10% A by 4 min, then to
50% A by 5 min, held at 50% A for 0.5 min then returned to
100% A. The same re-equilibration period as the previous
method was used. The QQQ mass spectrometer was oper-
ated in full scan (MS2Scan), between 500–1000 m/z with
a fragmentor voltage of 100 V and a cell accelerator volt-
age of 5 V in positive ionization mode. For determination
of CID spectra, collision energies of 5–40 eV were used and
the instrument operated in Product Ion Scan mode. Mass
transition of ONs were used in a targeted MRM method.
Data were analyzed using Agilent’s Qualitative Analysis
Software.
High-resolution mass spectra of oligonucleotide ions
were recorded by a Thermo Finnigan LTQ Orbitrap XL
with a heated electrospray ionization (HESI) source was op-
erated in positive ionization mode with a capillary voltage
of −10 V and temperature of 310◦C. The spray voltage to
3.3 kV, and the atmospheric pressure chemical ionization
(APCI) temperature was set to 135◦C. Sheath, auxiliary and
sweep gases were set to the following respectively 5, 35 and 7
arbitrary units. MS1 specta were collected from 200 to 1000
m/z and data-dependent acquisition (DDA) set to acquire
MS2 spectra of the top three most abundant ions. Data ac-
quisition and analysis was completed on the Thermo Xcal-
ibur software platform.
RESULTS
Exploring the applicability of a TEAA-free chromatography
for oligonucleotide mass spectrometry
In a first step, we wanted to find a TEAA (triethylammoniu-
macetate) and other ion-pairing reagents free chromatogra-
phy for separation of oligonucleotides which might be com-
patible with commonly used mass spectrometers and small
compound analysis. A literature search, to avoid ion-pairing
reagents, revealed amethod from 1994, where anRP-18 col-
umn was used for separation of tRNA isoacceptors (46).
Here, the elution was achieved by a gradient of simple am-
moniumacetate and acetonitrile, which is comparable to the
separation procedure of nucleosides (38). Inspired by this
early work, we tested the separation of synthetic oligonu-
cleotides (ON) on our nucleoside column (Phenomenex,
Fusion-RP) using a 10 mM ammonium acetate buffer and
acetonitrile for elution. Due to the negatively charged phos-
phate backbone of RNA, we did not expect good reten-
tion on a hydrophobic RP-18 column. However, due to the
special column material of the tested column, we observed
excellent retention for the tested ONs. As the UV chro-
matogram (260 nm) in Figure 1A shows, the tested 8-mer
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Figure 1. Separation and detection of synthetic oligonucleotides (ON) by MS. (A) UV chromatogram ( 260 nm) of various ONs (20 pmol injection)
separated by our ion-pairing reagent free chromatography. (B) Detection of the ONs from (A) by MS using positive ionization. (C) Detection of the ONs
from (A) by MS using negative ionization. (D) Mass spectrum of the first eluting ON from (A) in positive ion mode (black) and negative ion mode (gray)
on a low-resolution triple quadrupole instrument. The charge state is determined by the pattern of sodium charges in the spectrum. (E) Mass spectrum of
the first eluting ON from (A) in positive ion mode (black) on a high resolution Orbitrap instrument.
ONs elute first, followed by 9-mer ONs and 5-mer ONs. To
understand which properties of the ONs influence the re-
tention behavior, we used ONs, which only differ in one nu-
cleobase in their sequence. As shown in Figure 1A, the cy-
tidine containing 8-mer elutes first, while the exchange to
a uridine leads to better retention. The permutated 8-mer
with adenosine is retained most on the column. In the 5-
mer, we observe a better retention of the cytidine contain-
ing ON compared to its U containing permutation. In case
of the 9-mer ONs, the deamination of one adenosine into
inosine leads to reduced retention. In these sequence con-
texts, we clearly see a dependence of the retention behavior
on the chemistry of the present nucleobases and not on the
length of the ON. From our data, we conclude that the re-
tention behavior of ONs in our TEAA-free system depends
on two factors: the distribution of nucleobases and the se-
quence. We observe no rules which allow prediction of ON
elution.
In a next step, we connected our developed chromato-
graphic system with our low resolution triple quadrupole
(QQQ)mass spectrometer.We tuned the instrument in both
negative and positive ionization mode using the tune mix
supplied by the manufacturer and determined the opti-
mal source parameters for sensitive detection of ON 13
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(CCUAACACG) (Supplementary Figure S1). With these
parameters, we scanned for the eluting ONs in a mass range
of m/z 500–1000 in positive and negative ionization mode.
We received MS signals of all tested ONs below 10 nt in
both positive and negative ionization mode (Figure 1B/C).
Our instrument is commonly operated in positive ionization
mode, and thus it was no surprise to find a substantially
higher sensitivity in positive ionization mode. We attribute
this observation to the fact that the instrument is only op-
erated in positive ion mode with the respective buffers for
ideal protonation in the ESI source. Thus, the ionization
efficiency in negative ion mode is reduced. On other in-
struments, the sensitivity is higher in negative mode com-
pared to positive mode (47). We recommend assessment
of the most sensitive ionization mode on every mass spec-
trometer by running a mixture of short synthetic ONs. The
addition of the modifier 1,1,1,3,3,3-Hexafluor-2-propanol
(HFIP) did not improve the detection in positive or neg-
ative ion mode. Due to the common use of our instru-
ment in positive ion mode and the higher sensitivity, we de-
cided to use the positive ionization mode for further anal-
yses. We used the mongo-oligo mass calculator tool (https:
//mods.rna.albany.edu/masspec/Mongo-Oligo) to compare
our experimental signals with the predicted signals. For the
tested ONs, we observed the predicted m/z signals, com-
monly of the +2 charge state for 5 mers, +3 charge for 8
mers and +4 charge for 10mers (Supplementary Figure S2).
The charge state of an ON is commonly calculated with the
natural abundance of carbon-13 on high-resolution instru-
ments. The difference between the 12C-m/z value and the
13C-m/z value is∼1 in a +1 charge state,∼0.5 in a +2 charge
state, ∼0.3 in a +3 charge state, etc. On a low-resolution in-
strument, such as the used QQQ MS, the natural isotope
abundance is not resolved and cannot be used to predict
the charge state. As an alternative, the difference between
the (multi-) protonated ion and the sodium charged ion can
be used. In a +1 charge state, the difference is 22 units, in
a +2 charge state it is 11 units (charged by one protona-
tion and one sodium cation), in a +3 charge state it is ∼7
units (two protons and one sodium cation), etc. Our mass
spectrum for the C-permutated 8-mer ONs revealed a main
signal at m/z 808.1 (protonated species) and a m/z 816 for
the Na+-charge and thus we conclude a +3 charge state of
this ON (see Figure 1D). For the 8-mer ONs, other charge
states are of minor abundance (see full mass spectra in Sup-
plementary Figure S3).
In addition to the analyses of ONs by low resolutionMS,
we wanted to test the compatibility of our method with a
high resolution mass spectrometer. The instrument was op-
timized with the 9-mer ON 13 and the optimal parameters
were chosen according to the results given in Supplemen-
tary Figure S1. As shown in Figure 1E and Supplementary
Figure S2, all testedONswere detectable by high-resolution
MS in positive ionization mode. On this instrument Na+
adducts were of minor abundance and protonated species
dominated the MS spectra.
MS of oligonucleotides is commonly used to determine
the sequence and location of modified nucleosides (26,48).
For this purpose, fragmentation of the ONs by collision-
induced-dissociation (CID) is a useful tool and the behav-
ior of ONs in positive and negative ionization mode is well
described (47). On the low resolution QQQ instrument, we
analyzed ON 13 and ramped CID energies from 0 to 30 eV.
The recorded product ion scans are displayed in Figure 2A.
With increasing collision energy, the signal of the precur-
sor ion decreases, while multiple new signals appear in the
spectra. At higher collision energies, the most prominent
product ions in positive ionization mode are protonated
nucleobase fragment ions. At energies around 15–20 eV, c
and y ions become apparent (Figure 2B). Due to the low
resolution of a QQQ instrument, the charge state of these
c- and y-ions cannot be determined and thus QQQ MS is
not suitable for de novo sequencing. The signal to fragment
matching in Figure 2B and for other ONs in Supplemen-
tary Figure S4 was only possible due to the known sequence
of the ON and the use of the Mongo oligonucleotide tool
(https://mods.rna.albany.edu/masspec/Mongo-Oligo). CID
analysis on the high resolution MS produced more c- and
y- fragment ions of known charge states and thus de novo
sequencing is theoretically possible (Supplementary Figure
S5).
Low resolution instruments such as our used QQQ mass
spectrometer are commonly used for the sensitive detection
and quantification of small compounds. In our hands, the
LLOD and lower limits of quantification (LLOQ) of modi-
fied nucleosides is in the single digit fmol range or even amol
range (38). For ON analysis, we injected dilutions of ON
13 and ON 14 and found LLODs/LLOQs of 200 fmol in
MS2Scan mode, 800 fmol in MS/MS mode and 800 fmol
in Product Ion (PI) Scan mode for sequence determina-
tion purposes (Figure 2C). For isolated tRNA isoacceptors,
the lowest sensitivity was achieved with a TEAA dependent
nano-LC setup (33). With nano-LC, 2–5 ng tRNA (∼80–
200 fmol) are sufficient for analysis which is comparable to
our results.
Although the sensitivity towards ONs is lower compared
to small molecule analysis, it is sufficient to analyze ONs
derived from synthesis, in vitro experiments or potentially
even native RNAs.
Preparation of in vitro transcribed tRNA by SEC
To expand the field of application, we wanted to use our
method on partial RNA digests of full-length in vitro tran-
scripts and also native RNAs. Thus, we decided to pro-
duce two human tRNAs by ribozyme-fusion in vitro tran-
scription and analyze the transcripts after RNase T1 di-
gestion by ON-MS. After transcription, the cleaved tran-
script is commonly purified by PAGE and the ribozyme and
the full-length transcript are removed (49). However, PAGE
purified RNA always contains small amounts of polyacry-
lamide, which potentially interacts with later MS. Thus, we
adapted a previously described method based upon size ex-
clusion chromatography (SEC, SEC-3 column) that is rapid,
automatable and produces clean RNA (44). We have found
the AdvanceBio SEC column to be more robust and thus
recommend this column for tRNA purification from total
RNA. We supply a detailed handling guide to prolong col-
umn lifetime to several hundred injections in the materi-
als and methods section. A comparative profile of an RNA
ladder (1000 nts to 50 nts) loaded onto these two 300 A˚
columns is shown in Figure 3A and B. Especially at the used
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Figure 2. Collision-induced dissociation (CID) and sensitivity of oligonucleotides on a low resolution triple quadrupole mass spectrometer (30 pmol
injection). (A) MS/MS spectra of the 8-mer CCUAACACG at various collision energies (CID 0–30 eV). The emergence of base fragments is indicated
with [B+H]+. (B) MS/MS spectrum of CCUAACACG at a CID energy of 15 eV. The resulting fragments are assigned to the known sequence by using
(https://mods.rna.albany.edu/masspec/Mongo-Oligo). Base fragments are abbreviated with C––cytosine, A––adenine and G––guanine. (C) LLOD for the
ONs U(U/C)UCCCCG in MS scan mode (left), targeted MS mode (middle) of the mass transition 808.1→112 and 808.5→112 and MS/MS scan mode
using the precursor m/z 808.1 and 808.5. The upper graphs are above the LLOD, the lower graphs are just below the LLOD.
column temperature of 60◦C, both columns nicely separate
the 50 and 80 nts marker from the longer RNAs >150 nts.
As expected, native tRNA elutes at the same time as the 80
nts marker, which indicates that secondary structures play
no role in the separation of RNAs. Thus, these columns
are ideal for separation of large RNAs such as ribosomal
RNA (rRNA) and mRNA from the smaller tRNAs. The
AdvanceBio column is also available with a 130 A˚ pore size.
We tested the separation efficiency of this column with the
ladder and as it is to be expected, the large RNA markers
can no longer be separated due to reduced interaction with
the smaller pores (Figure 3C). The 130 A˚ column is less suit-
able for the separation of total RNA. However, it has a po-
tential for the separation of RNAs smaller 80 nts, e.g. tRNA
and tRNA-derived fragments (tRF or tiRNA) (Supplemen-
tary Figure S6).
For the sake of column preservation, we tested the chro-
matographic resolution at lower temperatures. We find suf-
ficient separation of the small 80 nts from the larger RNAs
(>150 nts) at 40◦C (Supplementary Figure S7). We have ap-
plied the AdvanceBio 300 A˚ SEC column at 40◦C in several
studies for the purification of tRNA from total RNA (5,50–
51). The purificationwas always reliable and thus we recom-
mend this column with the developed parameters for tRNA
purification.
For the purification of tRNA from ribozyme-fusion in
vitro transcription, both 300 A˚ and 130 A˚ pore size columns
have been tested. tRNASerUGA is an 85 nts long tRNA
and fused with the ribozyme fusion transcript is 135 nts in
length. The fusion transcript auto-catalytically cleaves itself
into the 85 nts long tRNA and the 40 nts long ribozyme.
As shown in Figure 3D, the tRNA peak is separated from
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Figure 3. SEC of RNA for automated purification (A)-(C) Separation of an RNA ladder (black) of a: 1000 nts, b: 500 nts, c: 300nts, d: 150 nts, e: 80 nts
and f: 50 nts. For comparison, the elution of total tRNA is shown in green. (A) SEC-3, 300 A˚ (B) AdvanceBio SEC 300 A˚ (C)AdvanceBio SEC 130 A˚ (D)
Purification of T7 in vitro transcribed tRNAValAAC (blue) and tRNASerUGA (red) on a 130 A˚ column at 60◦C. Peak 1: tRNA-ribozyme fusion product,
Peak 2: tRNA, Peak 3: ribozyme; (E)Quality control of the T7 transcription mix before purification (pre) and after SEC separation (post) for tRNAValAAC
and tRNASerUGA on an automated gel-electrophoresis system. 1: tRNA-ribozyme fusion product, 2: tRNA, 3: ribozyme
the full-length transcript, while the cleaved ribozyme partly
co-elutes with the tRNA (130 A˚ column at 60◦C). We col-
lected the tRNA peak and analyzed the fraction by high-
resolution automated electrophoresis (Bioanalyzer). Here,
we find that some of the ribozyme (40 nts) is still detectable
in the tRNA fraction but the full-length transcript (135 nts)
is completely removed (Figure 3E). If necessary, the collec-
tion of the tRNA peak is possible in a smaller time win-
dow or second purification round and thereby the ribozyme
can be completely removed (Supplementary Figure S8). Af-
ter successful purification of the comparably long tRNASer,
we were curious whether purification of a tRNA with short
variable loop is possible by our automated system. For this
purpose, we prepared a fusion-transcript of tRNAValAAC.
The full-length transcript is 124 nts long, the tRNA itself 76
nts and the ribozyme again 40 nts. For this tRNA, the size
difference between tRNA and the ribozyme is only 36 nts.
As a rule of thumb, SEC separation of biomolecules is pos-
sible as long as they differ in size by a factor of two. This pre-
requisite is not met in case of tRNAVal and as expected, the
separation of the produced tRNA and the ribozyme is not
possible (Figure 3D, blue chromatogram). The ribozyme
co-elutes as a shoulder and subsequently, more ribozyme
can be found in the purified tRNA transcript (Figure 3E).
Similar to the presented solution for tRNASer, a reduced
collection time window can help to remove the remaining
ribozyme if complete removal of the ribozyme is necessary
for subsequent experiments.
Overall, SEC purification of ribozyme-fusion transcribed
tRNAs is an alternative to purification by PAGE. The com-
plete transcription mix can be loaded onto the SEC column
without pre-purification and within 20 min the pure tRNA
fraction is received in a volume of 500–1000 l in 0.1 M
ammonium acetate. Concentration of the tRNA product is
possible by subsequent solvent evaporation and/or ethanol
precipitation.
Analysis of RNase T1 treated tRNA by oligonucleotide mass
spectrometry
With the tRNA transcripts in hand, we were ready to test
our LC-MS method by injecting a partial digest of the pro-
duced tRNAs. For this purpose, 1 g of each transcript
was incubated with RNase T1. The enzyme was removed by
molecular weight cut-off filtration and 200 ng (∼8 pmol) of
the resulting ON mixture were injected onto the LC-QQQ
set-up in scanning mode. As expected from our experiments
with synthetic ONs, we observe separation of the RNase T1
derived ONmixture as seen for the total ion chromatogram
shown in Figure 4A (tRNAValAAC) and 4b (tRNASerUGA).
The color-coded tRNA sequences are shown in Supplemen-
tary Figure S9. For tRNAValAAC, we prepared transcripts
containing stable isotope labeled nucleotides 15N3-cytidine
or 15N5-guanosine. The fragments of the unlabeled and la-
beled transcripts elute at the same retention time. The low
resolution mass spectra of the eluting peaks allowed the as-
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Figure 4. MS chromatograms of in vitro transcribed (IVT) tRNAs after RNase T1 digestion. (A) Extracted ion chromatograms of tRNAValAAC IVT
without stable isotopes (light ivt), with 15N3-Cytidine or 15N5-Guanosine. The sequences of the numbered peaks were determined by low resolution MS.
The retention time (Rt), charge state andm/z values for the unlabeled and stable isotope labeled sequences are given in the table. (B) Total ion chromatogram
of tRNASerUGA IVT. The sequences of the numbered peaks were determined by low-resolution MS and are listed below the chromatogram.
signment of the ON sequences, which are derived from var-
ious sequences of the tRNA. As expected, we observe dif-
ferences in the m/z value due to the stable isotopes in the
15N containing fragments compared to the unlabeled frag-
ments (Figure 4A). Thus, our method is capable of sepa-
rating RNase T1 derived tRNA digests. In this context, we
observed a low MS abundance of the 9 mer fragment (#4)
compared to the 8 mer fragment (#6) from tRNAVal. This
is explained by the different amount of acetonitrile (ACN)
at these retention times. While the 9-mer elutes at around
4.5% ACN, the 8-mer elutes later and with ∼ 25% ACN.
With higher amounts of ACN, the ionization efficiency is
increased and thus later eluting compounds have a higher
signal intensity. When the gradient is eliminated by direct
injection of ONs or elution at isocratic ACN conditions
(Supplementary Figure S2), the abundance of all injected
synthetic ONs is comparable and thus we conclude that the
ionization efficiency is not majorly impacted by the compo-
sition of canonical nucleosides.
RNA and especially tRNA are heavily post-
transcriptionally modified. To study the applicability
of our method to native RNA, we treated total tRNA
from HEK cell culture with RNase T1, separated the
resulting fragments with our chromatographic method
and analyzed the effluent by high-resolution MS. Here,
the mass resolving power of the Orbitrap instrument is
necessary to confirm the sequence and modification status
of the observed tRNA derived ONs. With this approach,
we could identify several modified ONs from total tRNA.
The corresponding chromatograms and MS/MS spectra
are shown in Figure 5.
ADAT2/3 deaminates tRNAValAAC at position 34 in vitro
Since tRNA modifying enzymes depend on a correctly
folded tRNA substrate for their activity, we tested whether
the SEC purified IVTs fold into the expected tRNA shape
and are thus usable in in vitromodification assays. For these
assays, we used human ADAT2/3 enzyme, which has been
shown to catalyze the deamination of wobble adenosine at
position 34 of in vitro transcribed tRNAValAAC to inosine
(52).We incubated tRNAValAAC with purifiedADAT2/3 ex-
pecting deamination of A34 to I34. The presumably deami-
nated tRNAwas digested by RNase T1 and we screened for
the tRNA sequence covering position 34, namely CCUAA-
CACG and CCUIACACG (see Figure 6A). Surprisingly,
we only found the unmodified sequence CCUAACACG
and not the inosine containing sequence (Figure 6B). Due
to this unexpected result, we digested an aliquot of the
ADAT2/3 treated tRNA to nucleosides and switched to
quantitative nucleoside analysis. While no inosine was de-
tected in the untreated tRNA by nucleoside MS, we could
detect an 8.0% conversion of adenosine to inosine per
tRNA molecule in the ADAT2/3 modified transcript (Fig-
ure 6F). From this finding we conclude that our SEC puri-
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Figure 5. Extracted ion chromatograms andMS/MS spectra of modified RNA fragments fromHEK 293 cell total tRNA digested with RNase T1. Spectra
were recorded on a high-resolution Orbitrap instrument at CID energies of 35 eV. Fragments were assigned using (https://mods.rna.albany.edu/masspec/
Mongo-Oligo) calculations from known modified tRNA sequences (acquired from modomics database).
fied tRNA folds correctly and is thus recognized as a sub-
strate by the tRNA modifying enzyme ADAT2/3.
Intrigued by the absence of the inosine modified ON in
the Oligo-MS analysis and with the goal to assign the lo-
cation of the A-to-I editing in tRNAValAAC, we utilized
the synthetic 9-mer ONs presented in Figure 1A. These
ONs represent the sequences expected from an RNase
T1 digestion of tRNAValAAC (unmodified: CCUAACACG
and modified: CCUIACACG). RNase T1 is a commonly
used endoribonuclease, which specifically cleaves RNA af-
ter guanosine moieties. Guanosine and adenosine differ at
position 6 and position 2 of their purine structures. Ino-
sine and guanosine are identical at position 6 but differ at
position 2. Due to the high chemical similarity of inosine
and guanosine, we wondered whether RNase T1 is capa-
ble of inosine recognition and subsequent cleavage. A lit-
erature search revealed that the detection of inosine by se-
quencing is commonly done utilizing RNase T1 (53,54).
In MS-based RNA modification studies, this knowledge is
not yet widespread. To test the impact of RNase T1 on I
containing RNA in MS, we incubated the A and I con-
taining ONs with RNase T1 and analyzed the resulting
mixture. For CCUAACACG, we observe one prominent
peak which corresponds to the full-length ON and a sec-
ond peak (less than 30%), corresponding to the 3′cleavage
product ACACG (Supplementary Figure S11). In contrast,
full-length CCUIACACG, is barely detectable after RNase
T1 treatment. Instead, two new peaks are found (Supple-
mentary Figures S10 and 11). One corresponds to the 3′
fragment ACACG and the other to the inosine contain-
ing 5′ cleavage product CCUI (Supplementary Figure S10).
From our observation it is now clear, that RNase T1 cleaves
both guanosine and inosine containing RNA sequences
which impacts bottom-up oligonucleotide mass sepctrom-
etry. Based upon our results, the substrate preference of
RNase T1 can now be summarized as G > I > A.
In case of tRNAValAAC, RNase T1 will then result in an
additional cleavage after I34 (Supplementary Figure S12).
We re-analyzed ADAT2/3 treated and untreated tRNA by
oligonucleotide MS and screened for the newly identified
ONs. We detected the CCUI fragment in unlabeled and
15N-Cytidine-labeled tRNA digests after ADAT2/3 treat-
ment, which indicates the A-to-I conversion of position 34
of the tRNA. Due to the similar mass of the CCUI and
the CCUA fragment (1 Da), the result must be confirmed
in the +1 charge state on a low resolution instrument or
by high resolution MS. Analysis of the sample on the Or-
bitrap instrument revealed indeed formation of CCUI and
thus confirms our findings from low resolution MS (Sup-
plementary Figure S13). For quantification of the deami-
nation reaction, we used the synthetic ON CCUIACACG
and prepared an external calibration with its RNase T1 di-
gest and re-analayzed the samples on the QQQMS. We de-
tected 7.6% inosine formation using this external calibra-
tion method (Figure 6C and D). Mass spectrometric quan-
tification is ideally done using stable isotope labeled inter-
nal standards. Here, we used our 15N3-cytidine labeled tran-
script of tRNAVal as the substrate and the unlabeled syn-
thetic ON as the internal standard. With this method, we
find a 6.2% conversion of A34 to I34 (Figure 6E). This re-
sult is 1.3-fold lower compared to our accurate nucleoside-
MS method (Figure 6F), which is acceptable for most po-
tential applications of our method. Our data suggests that
our method is capable of absolute quantification, but fur-
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Figure 6. In vitromodification of tRNAValAAC by ADAT2/3. (A) 3D structure of tRNAValAAC in green. In red, the RNase T1 fragment of the ADAT2/3
target site is shown. (B) RNase T1 digest of untreated (left) and ADAT2/3 treated (right) tRNAValAAC. In black, the signal for the resulting A-containing
ON is shown and in gray, the signal of the I-containing ON. (C) Calibration curve of the CCUI fragment for external calibration quantification by low-
resolution oligonucleotide MS. (D) Extracted ion chromatograms of RNase T1 digested tRNAValAAC before (black) and after (red) ADAT2/3 treatment.
In gray the synthetic CCUI oligo is shown as a retention time control. (E) Extracted ion chromatograms of RNase T1 digested 15N3-cytidine-labeled
tRNAValAAC before (black) and after (red) ADAT2/3 treatment. In gray the signal of the spiked in synthetic CCUI oligo is shown. (F) Quantification of
ADAT2/3 treated tRNA reveals the abundance of inosine per tRNA (%I / tRNA). Quantification was achieved by isotope dilution MS of a complete
nucleoside digest (Nucs-MS), by external calibration and by isotope standard spike-in for oligonucleotide MS.
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ther studies using internal standards as suggested by (39–
43) must be performed to determine the accuracy and pre-
cision for a given biological context.
The activity of AlkB is sequence dependent
Another context which benefits from ON-MS on a low
resolution MS, is in vitro modification/demodification ex-
periments. Here, we applied our method to the analysis
of 1-methyladenosine (m1A)-modified ONs to study the
demethylation by AlkB (8). With the goal to study the sub-
strate specificity of AlkB by ON-MS, we designed three
m1A-containing ONs. In human tRNA, m1A is commonly
found at position 58. Sequence overlay of 13 random hu-
man tRNAs revealed the weight matrix of the nucleobases
surrounding m1A58 in human tRNAs (Supplementary Fig-
ure S14). The first ON (UUCG(m1A)UUC), was designed
to match this sequence surrounding m1A58 from human
tRNAs and is thus referred to as ON-human. The sec-
ond ON reflects a mutated version of the ON-human,
where three preserved bases are exchanged (ON-mutated,
UAGG(m1A)UUG). The last ON, ON-ribo, reflects the se-
quence surrounding the only possible m1A site of E. coli
16S rRNA; (CGUC(m1A)CAC). This site is found to be
methylated in bacteria resistant to certain antibiotics (55).
With this experiment, we wanted to evaluate the activity of
AlkB toward these three ONs and whether a sequence de-
pendence is observable.
All three ONs were incubated with 10 M AlkB. The
subsequent ON-MS analysis revealed the formation of
demethylated ONs as shown in Figure 7A–C. The demethy-
lated ONs elute at a later retention time compared to the re-
spective m1Amodified ONs on our TEAA-free chromatog-
raphy due to the lost positive charge of m1A. For ON-
human andON-ribo, we observe only trace formation of the
demethylated ON (Figure 7A/C). In contrast, we observed
more demethylated ON for ON-mutated. At first glance,
our observation indicates that them1A site ofE. coli rRNA,
and the ON with the sequence of eukaryotic tRNA m1A58
are less suitable substrates to AlkB compared to the com-
pletely unnatural substrate, ON-mutated. However, with-
out the use of stable isotope labeled internal standards, MS
is non-quantitative and the data may not be interpreted in
such a way.
To provide a quantitative method, we digested the AlkB
treated and untreated ONs to nucleosides and performed
nucleoside-MS with our established stable isotope dilution
MS (38). For this purpose, we equilibrated the system for
1 h by flushing the instrument with our aqueous nucleoside-
MS buffer and performed our quantitative nucleoside ex-
periments. Before AlkB treatment, we find 0.23 m1A per
ON-human, 0.12 m1A per ON-mutated and 0.19 m1A per
ON-ribo. At a low AlkB concentration (1 M), we observe
9.8% demethylation for the ON-human (P = 0.0067). The
ON-mutated shows 12.9% demethylation (P < 0.0001) and
the ON-ribo 18.6% demethylation (P < 0.0001). The ab-
solute quantification data is in stark contrast to the non-
quantitative results observed by the oligonucleotideMS. In-
triguingly, AlkB seems to prefer the only potential m1A site
found in bacteria, namely m1A1408 of the 16 S rRNA. Our
observation is confirmed by incubation of the same ONs
Figure 7. in vitro AlkB assay with different m1A containing oligonu-
cleotides (ON) (A–C) left: ON-MS of m1A containing ONs after incuba-
tion with 10 M AlkB and their assigned m/z values, charge states and
sequences. (A–C) right: amount of m1A per ON determined by isotope
dilution MS of fully digested ONs with and without 1 M AlkB treat-
ment; bars represent the mean, error bars the standard deviation, n = 3
biological replicates, a two-tailed, unpaired students t-test was performed
(ON-human:P= 0.0067; ON-mutated:P< 0.0001; ON-ribo:P< 0.0001).
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Table 1. Advantages and Limitations of TEAA-free and other commonly used ON-MS methods
TEAA-based ON-MS TEAA free low-resolution MS TEAA free high-resolution MS
Analysis of native RNA
• Known sequence yes yes yes
• Unknown sequence yes no yes
Analysis of synthetic ONs yes yes yes
Analysis of ONs longer 10 nts no no no
Compatibility with small compound
analyses
no yes yes
LC and MS contamination yes no no
2D analysis (57) yes no no
Sensitivity Lower compared to
nucleoside MS
Lower compared to nucleoside
MS
Lower compared to nucleoside
MS
Quantitative accuracy and precision (39–43) Not fully determined Not fully determined
with higher amounts of AlkB (10 M, Supplementary Fig-
ure S15).
DISCUSSION
In this manuscript we present a method for the separation
of oligonucleotides and subsequent detection by oligonu-
cleotide MS (ON-MS). While methods for ON-MS have
been available for several years, key hurdles toward their
broader application were the use of ion-pairing reagents
such as TEAA and negative ionization. We have overcome
these hurdles by successfully using a modified RP-18 col-
umn with a simple ammonium acetate buffer in combina-
tion with acetonitrile. These are common solvents for LC-
MS instruments, which do not contaminate the system or
interfere with subsequent analysis of other compounds. The
broad applicability is demonstrated by our analyses of syn-
thetic ONs, RNase T1 digestion derived RNA fragments of
in vitro transcripts and native tRNA on both low and high-
resolution mass spectrometers. A higher resolving power is
required to distinguishmass differences of oligonucleotides,
their sequence and modification content. A key challenge is
that the nucleotide bases uridine and cytidine (and adeno-
sine and inosine) have a mass difference of only 1 Da, which
is already the resolution limit of the QQQMS. For the anal-
ysis of unknown sequences, themass accuracy and resolving
power of the mass spectrometer must therefore be sufficient
to resolve this difference (56). A second benefit of high res-
olution MS, is the determination of charge states even in
MS/MS experiments which allows sequence determination
and localization of modified nucleosides as demonstrated in
Figure 5.
Nevertheless, low resolution MS instruments are valu-
able for the analysis of oligonucleotides of known sequence
which have been prepared for e.g. in vitro analysis of RNA
modifying (Figure 6) or demethylating enzymes (Figure 7).
A single sample run is <15 min and ONs below 10 nt are
separated according to their chemistry, but the elution order
is not predictable. Thus 2D analysis of sequences as shown
by the Szostak lab is not possible with our method (57). In
our hands, switching from ON-MS to sensitive nucleoside-
MS is possible within 60 min to allow system and column
equilibration. A comparison of our TEAA free and the
common ON-MS method is given in Table 1.
For the analysis of RNA modifying enzymes, the prepa-
ration and use of in vitro transcribed RNA is highly useful.
In this manuscript, we use ribozyme-fusion transcription
of a 76 nts long tRNA and an 85 nts long tRNA. Instead
of laborious PAGE purification, we use automated SEC.
With nucleoside-MS (Figure 6F), we show that the thus
purified tRNA is recognized and converted by ADAT2/3,
which demonstrates the correct folding of the tRNA. With
the goal to determine the position of A-I conversion, the
produced tRNAs are digested by RNase T1 and the result-
ing fragments are separated by our TEAA-free chromatog-
raphy. It is noteworthy that our chromatography allows the
separation of ONs where only one oxygen is replaced with
an amino group. The RNase T1 derived fragments are as-
signed by the detected m/z values in positive ionization
mode by low resolution MS (Figures 4 and 6). For such
in vitro experiments, there is no immediate need for high-
resolutionMS as the resulting fragments andMS/MSprod-
ucts can be predicted and resolved by low resolutionMS. In
case of the studied A-I conversion, the target fragment dif-
fers in only 1 Da, which can be resolved by low-resolution
MS in the +1 charge state, but not in higher charge states.
In such cases, the use of high-resolution instruments might
become necessary for confirmation (Supplementary Figure
S13).
We observe efficient cleavage after inosine by RNase
T1 in the A-I converted tRNA and synthetic ONs as ex-
pected from approaches to sequence inosine containing
RNA (53,54). This substrate diversity of RNase T1 is not
commonly described in the bottom-up-MS literature but
due to the high abundance of inosine in tRNA (6) and
mRNA (58) it should be kept in mind when using RNase
T1.
Altogether, we present various MS-based approaches for
the bottom-up analysis of RNA which are easily trans-
ferrable to laboratories which avoided ON-MS in the past
due to the problems introduced by ion-pairing reagents and
negative ion mode. We demonstrate that switching from
ON-MS to small compound analysis and back is possible
after a brief equilibration procedure (Figures 6 and 7).With
this, ON-MS can be routinely used on any LC-MS system
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